India to Philippines: Amphotericin Export Trade Route
India has recorded 29 verified shipments of Amphotericin exported to Philippines, representing a combined trade value of $3.7M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $125.9K USD. The leading Indian exporter is BHARAT SERUMS AND VACCINES LIMITED, which accounts for 73% of total export value with 19 shipments worth $2.7M USD. On the buying side, BSV BIOSCIENCE PHILIPPINES INC. is the largest importer in Philippines with $1.5M USD in purchases. The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , U SQUARE LIFESCIENCE PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Amphotericin corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $3.7M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 73% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $125.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with amphotericin's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 7.4%, placing it at rank #20 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in Philippines include BSV BIOSCIENCE PHILIPPINES INC., BSV BIOSCIENCE PHILS. INC , BSV BIOSCIENCE PHILIPPHINES. and 10 others. BSV BIOSCIENCE PHILIPPINES INC. is the single largest importer with 9 shipments valued at $1.5M USD.
